UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Costs of Employees with Treatment-Resistant Depression Based on a Canadian Private Claims Database

Value in health, 2014-11, Vol.17 (7), p.A456-A457

2014

Volltextzugriff (PDF)

Physical vapor transport growth of large AlN crystals

Journal of crystal growth, 2003-03, Vol.250 (1), p.107-112

2003

Volltextzugriff (PDF)

Improvement of hERG-ROMK index of spirocyclic ROMK inhibitors through scaffold optimization and incorporation of novel pharmacophores

Bioorganic & medicinal chemistry letters, 2017-06, Vol.27 (11), p.2559-2566

2017

Volltextzugriff (PDF)

The anesthetized guinea pig: An effective early cardiovascular derisking and lead optimization model

Journal of pharmacological and toxicological methods, 2013-07, Vol.68 (1), p.137-149

2013

Volltextzugriff (PDF)

BRL 34915 (Cromakalim) Activates ATP-Sensitive K+ Current in Cardiac Muscle

Proceedings of the National Academy of Sciences - PNAS, 1988-11, Vol.85 (21), p.8360-8364

1988

Volltextzugriff (PDF)

A highly sensitive canine telemetry model for detection of QT interval prolongation: Studies with moxifloxacin, haloperidol and MK-499

Journal of pharmacological and toxicological methods, 2007-09, Vol.56 (2), p.103-114

2007

Volltextzugriff (PDF)

Nonpeptide angiotensin II antagonists derived from 1H-pyrazole-5-carboxylates and 4-aryl-1H-imidazole-5-carboxylates

Journal of medicinal chemistry, 1993-11, Vol.36 (23), p.3595-3605

1993

Volltextzugriff (PDF)

PMH19 - Costs of Employees with Treatment-Resistant Depression Based on a Canadian Private Claims Database

Value in health, 2014-11, Vol.17 (7), p.A456-A457

2014

Volltextzugriff (PDF)

Pharmacology of L-754,142, a highly potent, orally active, nonpeptidyl endothelin antagonist

The Journal of pharmacology and experimental therapeutics, 1995-12, Vol.275 (3), p.1518

1995

Volltextzugriff (PDF)

Triazolinone Biphenylsulfonamides as Angiotensin II Receptor Antagonists with High Affinity for Both the AT1 and AT2 Subtypes

Journal of medicinal chemistry, 1994-12, Vol.37 (26), p.4464-4478

1994

Volltextzugriff (PDF)

Discovery of L-162,313: a nonpeptide that mimics the biological actions of angiotensin II

American journal of physiology. Regulatory, integrative and comparative physiology, 1995-03, Vol.268 (3), p.820-R823

1995

Volltextzugriff (PDF)

(Dipropylphenoxy)phenylacetic acids: a new generation of nonpeptide angiotensin II receptor antagonists

Journal of medicinal chemistry, 1993-11, Vol.36 (23), p.3738-3742

1993

Volltextzugriff (PDF)

A highly potent, orally active imidazo-[4,5-b]pyridine biphenylacylsulfonamide (MK-996;L-159,282) : a new AT1-selective angiotensin II receptor antagonist

Journal of medicinal chemistry, 1994-11, Vol.37 (24), p.4068-4072

1994

Volltextzugriff (PDF)

Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypes

Journal of medicinal chemistry, 1995-09, Vol.38 (19), p.3741-3758

1995

Volltextzugriff (PDF)

Non-peptide angiotensin II receptor antagonists. 1. Design, synthesis, and biological activity of N-substituted indoles and dihydroindoles

Journal of medicinal chemistry, 1993-12, Vol.36 (26), p.4230-4238

1993

Volltextzugriff (PDF)

Non-peptide angiotensin II receptor antagonists. 2. Design, synthesis, and biological activity of N-substituted (phenylamino)phenylacetic acids and acyl sulfonamides

Journal of medicinal chemistry, 1993-12, Vol.36 (26), p.4239-4249

1993

Volltextzugriff (PDF)

A potent, orally active, balanced affinity angiotensin II AT1 antagonist and AT2 binding inhibitor

Journal of medicinal chemistry, 1993-10, Vol.36 (21), p.3207-3210

1993

Volltextzugriff (PDF)

In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996

American journal of hypertension, 1995-01, Vol.8 (1), p.58-66

1995

Volltextzugriff (PDF)

Rat atriopeptin III alters hypothalamic neuronal activity

Neuroscience letters, 1986-06, Vol.67 (3), p.279-284

1986

Volltextzugriff (PDF)

A novel base feed design for high power, high frequency heterojunction bipolar transistors

2001 IEEE MTT-S International Microwave Sympsoium Digest (Cat. No.01CH37157), 2001, Vol.2, p.1075-1078 vol.2

2001

Volltextzugriff (PDF)

The development of orientation and direction selectivity in the rabbit visual cortex

Brain research, 1988-05, Vol.40 (2), p.315-318

1988

Volltextzugriff (PDF)

Quinazolinone Biphenyl Acylsulfonamides: A potent new class of angiotensin-II receptor antagonists

Bioorganic & medicinal chemistry letters, 1994-01, Vol.4 (1), p.75-80

1994

Volltextzugriff (PDF)

In Vivo Pharmacology of L-159,913, A New Highly Potent and Selective Nonpeptide Angiotensin II Receptor Antagonist

Clinical and experimental hypertension (1993), 1995, Vol.17 (6), p.931-953

1995

Volltextzugriff (PDF)

A new class of balanced AT1/AT2 angiotensin II antagonists : quinazolinone AII antagonists with acylsulfonamide and sulfonylcarbamate acidic functionalities

Bioorganic & medicinal chemistry letters, 1994-01, Vol.4 (1), p.81-86

1994

Volltextzugriff (PDF)

In vivo pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for angiotensin AT2 receptors

European journal of pharmacology, 1995-12, Vol.294 (2-3), p.439-450

1995

Volltextzugriff (PDF)

1 – 25 von 266

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(219)
Mit Volltextzugriff
(190)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Costs of Employees with Treatment-Resistant Depression Based on a Canadian Private Claims Database

Physical vapor transport growth of large AlN crystals

Improvement of hERG-ROMK index of spirocyclic ROMK inhibitors through scaffold optimization and incorporation of novel pharmacophores

The anesthetized guinea pig: An effective early cardiovascular derisking and lead optimization model

BRL 34915 (Cromakalim) Activates ATP-Sensitive K+ Current in Cardiac Muscle

A highly sensitive canine telemetry model for detection of QT interval prolongation: Studies with moxifloxacin, haloperidol and MK-499

Nonpeptide angiotensin II antagonists derived from 1H-pyrazole-5-carboxylates and 4-aryl-1H-imidazole-5-carboxylates

PMH19 - Costs of Employees with Treatment-Resistant Depression Based on a Canadian Private Claims Database

Pharmacology of L-754,142, a highly potent, orally active, nonpeptidyl endothelin antagonist

Triazolinone Biphenylsulfonamides as Angiotensin II Receptor Antagonists with High Affinity for Both the AT1 and AT2 Subtypes

Discovery of L-162,313: a nonpeptide that mimics the biological actions of angiotensin II

(Dipropylphenoxy)phenylacetic acids: a new generation of nonpeptide angiotensin II receptor antagonists

A highly potent, orally active imidazo-[4,5-b]pyridine biphenylacylsulfonamide (MK-996;L-159,282) : a new AT1-selective angiotensin II receptor antagonist

Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypes

Non-peptide angiotensin II receptor antagonists. 1. Design, synthesis, and biological activity of N-substituted indoles and dihydroindoles

Non-peptide angiotensin II receptor antagonists. 2. Design, synthesis, and biological activity of N-substituted (phenylamino)phenylacetic acids and acyl sulfonamides

A potent, orally active, balanced affinity angiotensin II AT1 antagonist and AT2 binding inhibitor

In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996

Rat atriopeptin III alters hypothalamic neuronal activity

A novel base feed design for high power, high frequency heterojunction bipolar transistors

The development of orientation and direction selectivity in the rabbit visual cortex

Quinazolinone Biphenyl Acylsulfonamides: A potent new class of angiotensin-II receptor antagonists

In Vivo Pharmacology of L-159,913, A New Highly Potent and Selective Nonpeptide Angiotensin II Receptor Antagonist

A new class of balanced AT1/AT2 angiotensin II antagonists : quinazolinone AII antagonists with acylsulfonamide and sulfonylcarbamate acidic functionalities

In vivo pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for angiotensin AT2 receptors

Suchergebnisse filtern